Relevant Health Care Price Info Hard to Find Online

Share this content:
Relevant Health Care Price Info Hard to Find Online
Relevant Health Care Price Info Hard to Find Online

MONDAY, Dec. 4, 2017 (HealthDay News) -- Overall, 17 percent of websites provide geographically relevant health care price estimates relating to specific interventions, according to a research letter published online Dec. 4 in JAMA Internal Medicine.

Allison Kratka, from Duke University in Durham, N.C., and colleagues examined the availability of price information for four nonemergency medical interventions. Searches were conducted for eight U.S. cities, and results were included from 1,726 websites from 64 searches; 1,346 of the websites were not advertisements.

The researchers found that 21.9 percent of the websites were price transparency sites relevant to the intervention in question; 28.4 percent linked to single providers/clinics; 4.7 percent provided quality information without prices; and 27.6 and 17.4 percent, respectively, provided generic information and unrelated information. Across health care interventions the categories of search results differed significantly. Seventeen percent of sites provided geographically relevant price estimates, with significant variation by intervention. There was a difference by location in the proportion of websites providing at least one geographically-relevant price estimate, varying from 27.3 percent in Chicago to 7.1 percent in Baltimore. Most websites did not specify whether the price quoted was the consumer's out-of-pocket cost; there was considerable variation in the prices listed on the sites within interventions.

"Our findings suggest that there is substantial room for improvement in providing consumers with ready access to health care prices online," the authors write. "Policy makers should consider mandating that payers and providers make these prices available to consumers."

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

ASH: Anti-CD19 CAR T-Cell Tx Beneficial in B-Cell Lymphomas

ASH: Anti-CD19 CAR T-Cell Tx Beneficial in B-Cell ...

Second study shows benefit in relapsed or refractory B-cell lymphoma, follicular lymphoma

ASH: AAVD Beats ABVD for Advanced Hodgkin's Lymphoma

ASH: A+AVD Beats ABVD for Advanced Hodgkin's Lymphoma

Lower combined risk of progression, death, or noncomplete response with A+AVD

ASH: High-Dose Gene Transfer Beneficial in Severe Hemophilia A

ASH: High-Dose Gene Transfer Beneficial in Severe Hemophilia ...

Factor VIII gene transfer tied to sustained normalization of factor VIII activity levels

is free, fast, and customized just for you!

Already a member?

Sign In Now »